Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2005 | Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R | Gow C.-H.; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU | PLoS Medicine | 25 | 0 | |
2019 | Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer | Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU ; Chang T.-H.; TZU-HSIU TSAI ; Gow C.-H.; YIH-LEONG CHANG ; JIN-YUAN SHIH | International Journal of Cancer | 34 | 34 | |
2008 | Clinical response of gefitinib on malignant pleural effusions in patients with non-small cell lung cancer | Chen C.-H.; Gow C.-H.; CHONG-JEN YU ; JIN-YUAN SHIH ; Hsu Y.-C.; Lee W.-Y.; PAN-CHYR YANG ; Kuo S.-H. | Journal of Cancer Molecules | 8 | ||
2021 | Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma | Gow C.-H.; MIN-SHU HSIEH ; Liu Y.-N.; Lee Y.-H.; JIN-YUAN SHIH | Cancers | 10 | 8 | |
2017 | Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas | Gow C.-H.; Chang H.-T.; Lim C.-K.; Liu C.-Y.; JIN-SHING CHEN ; JIN-YUAN SHIH | Genes Chromosomes and Cancer | 15 | 15 | |
2009 | Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer | Gow C.-H.; YIH-LEONG CHANG ; Hsu Y.-C.; Tsai M.-F.; CHEN-TU WU ; CHONG-JEN YU ; CHIH-HSIN YANG ; Lee Y.-C.; PAN-CHYR YANG ; JIN-YUAN SHIH | Annals of Oncology | 195 | 172 | |
2017 | A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population | Gow C.-H.; MIN-SHU HSIEH ; SHANG-GIN WU ; JIN-YUAN SHIH | Lung Cancer | 47 | 38 | |
2015 | Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib | Gow C.-H.; WEI-YU LIAO ; Liu Y.-N.; JIN-YUAN SHIH | Journal of Thoracic Oncology | 14 | 14 | |
2005 | EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer [2] (multiple letters) | JIN-YUAN SHIH ; Gow C.-H.; PAN-CHYR YANG | New England Journal of Medicine | 166 | 145 | |
2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | JIN-YUAN SHIH ; Gow C.-H.; CHONG-JEN YU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; Tsai M.-F.; Hsu Y.-C.; KUAN-YU CHEN ; Su W.-P.; PAN-CHYR YANG | International Journal of Cancer | 154 | 142 | |
2008 | First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; CHIH-HSIN YANG ; SHANG-GIN WU ; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG ; Hsu Y.-C.; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 69 | 62 | |
2008 | Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma | SHANG-GIN WU ; Gow C.-H.; CHONG-JEN YU ; YIH-LEONG CHANG ; CHIH-HSIN YANG ; Hsu Y.-C.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | European Respiratory Journal | 109 | 95 | |
2008 | Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response | Wu J.-Y.; SHANG-GIN WU ; CHIH-HSIN YANG ; Gow C.-H.; YIH-LEONG CHANG ; CHONG-JEN YU ; Shin J.-Y.; PAN-CHYR YANG | Clinical Cancer Research | 278 | 250 | |
2014 | Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case | Gow C.-H.; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH | Medical Oncology | 24 | 21 | |
2018 | Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer | Gow C.-H.; Liu Y.-N.; Li H.-Y.; MIN-SHU HSIEH ; Chang S.-H.; Luo S.-C.; TZU-HSIU TSAI ; PEI-LUNG CHEN ; Tsai M.-F.; JIN-YUAN SHIH | Neoplasia (United States) | 22 | 22 | |
2008 | Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response | Gow C.-H.; Chien C.-R.; YIH-LEONG CHANG ; Chiu Y.-H.; SUNG-HSIN KUO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Clinical Cancer Research | 132 | 125 | |
2006 | Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer | CHIH-HSIN YANG ; JIN-YUAN SHIH ; Chen K.-C.; CHONG-JEN YU ; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; CHIUN HSU ; Chang G.-C.; PAN-CHYR YANG | Cancer | 59 | 50 | |
2019 | Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas | Gow C.-H.; MIN-SHU HSIEH ; YEN-TING LIN ; Liu Y.-N.; JIN-YUAN SHIH | Cancers | 20 | 17 |